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CD28 as a Molecular Amplifier Extending
TCR Ligation and Signaling Capabilities
mice (Green et al., 2000) and/or by a compensatory
effect of increasing TCR engagement (e.g., stoichiome-
try and/or duration of engagement) (Ku¨ndig et al., 1996;
Fre´de´rique Michel, Ge´raldine Attal-Bonnefoy,
Giorgio Mangino, Setsuko Mise-Omata,
and Oreste Acuto1
Manickasingham et al., 1998). These data have suggestedMolecular Immunology Unit
that CD28 is a subsidiary receptor, although it may beDepartment of Immunology
essential for the production of Th-2-type cytokinesInstitut Pasteur
(Lenschow et al., 1996; Manickasingham et al., 1998).Paris
Many studies have investigated the biochemical na-France
ture of the CD28-mediated signal (Rudd, 1996; Ward,
1996), but its mechanistic basis remains unclear. CD28
can activate specific signaling elements that integrateSummary
those governed by TCR engagement. Thus, CD28-medi-
ated Rap-1 inhibition increases TCR-mediated Erk acti-Evidence has gathered that CD28 costimulation facili-
vation (Carey et al., 2000), and a signal from CD28 involv-tates T cell activation by potentiating TCR intrinsic-
ing Akt is needed for activating CD28RE of the IL-2signaling. However, the underlying molecular mecha-
promoter (Kane et al., 2001). However, the possibilitynism is largely unknown. Here we show that, by
exists that CD28 triggering also duplicates part of theenhancing T cell/APC close contacts, CD28 facilitates
TCR signaling circuitry. Such a quantitative complementTCR signal transduction. Moreover, the signal sup-
of the signal facilitates reaching a threshold above whichplied by CD28 does not lead to increased Zap-70 and
full activation occurs (Viola and Lanzavecchia, 1996).Lat phosphorylation, but amplifies PLC1 activation
Engagement of CD28 induces phosphorylation of tyro-and Ca2 response. We provide evidence that the PTK
sine residues in its intracellular tail by Src PTKs (RaabItk controls the latter function. Our data suggest that
et al., 1995) and binding of the regulatory subunit ofCD28 binding to B7 contributes to setting the level of
the phosphoinositide 3-kinase (PI3K) (Ward, 1996). InTCR-induced phosphorylated Lat for recruiting signal-
addition, triggered CD28 activates the PTKs Tec (Yanging complexes, whereas the CD28 signal boosts multi-
et al., 1999) and Itk (August et al., 1994), induces tyrosineple pathways by facilitating PLC1 activation. These
phosphorylation of signaling effectors such as PLC1,results should provide a conceptual framework for
Vav-1, c-Cbl (Ward, 1996), Pyk-2 (Tsuchida et al., 1999),understanding quantitative and qualitative aspects of
p62Dok (Yang et al., 1999), and induces threonine phos-CD28-mediated costimulation.
phorylation and activation of PKB/Akt (Parry et al., 1997).
With the exception of p62Dok, all these signaling compo-Introduction
nents have been reported to be phosphorylated upon
TCR ligation as well. The TCR, however, possesses itsThe signal following detection of antigen/MHC com-
own signaling “signature,” such as the activation ofplexes by the antigen receptor (TCR) is insufficient to
Zap-70 and phosphorylation of the adapters SLP-76 andelicit an immune response. To effectively activate gene
Lat, which are essential for connecting to the majorexpression leading to effector functions, T cells require
intracellular signaling pathways Ca2/calcineurin anda second signal from “professional” APCs (Schwartz,
Ras/Rac/MAP kinases (van Leeuwen and Samelson,1992). Thus, the integration of two signaling inputs, one
1999). Thus, the sharing of a subset of signaling ele-of variable strength by antigen/MHC (e.g., abundance
ments between the TCR and CD28 provides some sup-
and affinity for the TCR) and the other costimulatory,
port for a quantitative contribution of costimulation to
influences T cell fate. The membrane receptor CD28
T cell activation. In this respect, primary mouse T cells
plays a major role in providing costimulation for the stimulated by antigen-loaded activated B cells requires
activation of naive T cells upon engagement with its CD28 ligation by B7 for amplifying TCR- chain and Zap-
ligands B7.1 (CD80) and B7.2 (CD86), which are highly 70 tyrosine phosphorylation (Tuosto and Acuto, 1998).
expressed on activated APCs (Lenschow et al., 1996). Moreover, coengagement of CD28 promoted coales-
Indeed, a strong reduction of T cell-mediated responses cence of lipid microdomains (GEMs) (Viola et al., 1999),
was found in CD28-deficient mice (Green et al., 1994; the sites where TCR signaling appears to be organized
Shahinian et al., 1993) or in normal mice treated with (Janes et al., 2000). These data suggest that CD28
CTLA4-Ig, which antagonizes CD28-B7.1/B7.2 interac- costimulation may act on the earliest phase of TCR-
tion (Lenschow et al., 1996). However, other studies controlled activation.
have shown that, in the absence of CD28, full or residual To further understand this mechanism, we sought to
T cell functions can be elicited in some viral infections identify the specific signaling contributions of the TCR
(Shahinian et al., 1993) and in tissue transplantation and CD28 when they are triggered, individually or to-
(Saito et al., 1998). The dispensability of CD28 may be gether, under conditions closely mimicking physiologi-
explained by a partially redundant role of another costim- cal engagement. To this end, we utilized T cell lines
ulatory receptor, CD2, as suggested by studies with lacking CD28 or expressing CD28 wild-type or a CD28
CD2/ (Bachmann et al., 1999) and CD2//CD28/ signal-defective mutant and recorded the earliest bio-
chemical modifications induced by presentation of B7.1
and superantigen/class II complexes. Our data reveal1 Correspondence: oacuto@pasteur.fr
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Figure 1. CD3 and CD28 Expression in CH7C17 Cell Transfectants and IL-2 Gene Activation in Response to SEB
(A) FACS analysis of cells stained by indirect immunofluorescence with anti-CD3 (OKT3, dotted line) or anti-CD28 (CD28.2, gray line). Anti-
Ig/FITC (secondary Ab, black line).
(B) Cells were transfected with IL-2 promoter luciferase reporter plasmid and stimulated after 24 hr with 531-B7 pulsed with SEB at the
indicated concentrations. CD28WT cells (squares) were clones A14 (gray) and C20 (empty). CD28Del.30 cells (circles) were clones F5 (gray)
and B6 (empty). CD28Neg cells (triangles) were clone B2 (gray) and CH7C17 (empty).
that cell-cell contact mediated by CD28/B7 interaction G418-resistant cell line isolated from CD28 transfection.
These cell lines lacked CD2, but expressed very similarfacilitates TCR engagement and signaling. Moreover,
the signal emanating from the CD28 intracellular tail levels of CD11a/CD18, CD4, and CD45 (data not shown).
To mimic physiological conditions of TCR and CD28does not influence TCR-induced Zap-70 activation and
Lat phosphorylation, whereas it favors SLP-76 and engagement, we utilized SEB-pulsed 531-B7 cells,
which express similar levels of human MHC class II (DR1)PLC1 phosphorylation with consequent amplification
of the increase in intracellular Ca2 concentration, and B7.1 (Tuosto and Acuto, 1998). TCR engagement
kinetics and activation threshold by enterotoxin super-[Ca2]i. This mechanism involves CD28-mediated re-
cruitment/activation of the PTK Itk. Our data suggest antigen/MHC and peptide/MHC have been shown to be
similar (Viola and Lanzavecchia, 1996). SEB stimulated,that at low TCR occupancy, likely to occur under physio-
logical conditions, CD28 engagement facilitates TCR in a dose-dependent fashion, activation of the IL-2 mini-
mal promoter in CD28WT (Figure 1B). In contrast, weakengagement and recruits a specialized subset of ef-
fectors to boost a limiting TCR-dependent signal. This IL-2 gene transcription was induced in CD28Neg and
CD28Del.30 cells stimulated with SEB-pulsed 531-B7provides evidence for both quantitative and qualitative
contributions of CD28 to T cell activation. cells. Thus, IL-2 gene activation in Jurkat cells stimu-
lated by SEB-pulsed 531-B7 cells was dependent on
both CD28 expression and its intracellular region. ThisResults
system may therefore allow dissection of the biochemi-
cal mechanism by which CD28 influences TCR-depen-IL-2 Gene Activation in Jurkat Cells by SEB-Pulsed
APC Requires CD28 Signaling dent signaling.
Inhibition of CD28/B7 interaction sharply decreases
TCR-induced tyrosine phosphorylation of  and Zap-70 CD28 Enhancement of TCR-Mediated Tyrosine
Phosphorylations Correlates with CD28-Dependent(Tuosto and Acuto, 1998). This effect could be due to
CD28 ligation by B7 favoring TCR engagement with anti- T Cell/APC Conjugate Formation
First, we asked whether tyrosine phosphorylation of in-gen/MHC (Davis and van der Merwe, 1996). Alterna-
tively, CD28-mediated early biochemical changes might tracellular substrates was affected in the absence of
CD28. Figure 2A (right panel) shows that, after triggeringreinforce those emanating from the TCR, implying mem-
brane-proximal merging of the two signaling pathways. by B7.1, proteins of 120–110, 95, and 62 kDa were phos-
phorylated on tyrosine in CD28WT but not in CD28NegHowever, both of these mechanisms could operate at
the same time. To discriminate between these hypothe- cells. The 95 and 62 kDa species were Vav-1 (Michel et
al., 2000) and p62Dok proteins (Figure 2B), respectively.ses, we made use of a Jurkat cell line (CH7C17) deficient
for CD28 expression (CD28Neg) and transfectants of it The controls, shown in Figure 2A (left panel), demon-
strate that minimal or no inducible phosphorylation isreconstituted with human CD28 wild-type (CD28WT) or
a signal-deficient CD28 mutant lacking the 30 C-terminal elicited in Jurkat cells in the absence of B7 stimulation.
When CD28WT cells were stimulated with SEB-pulsedresidues (CD28Del.30) (Pages et al., 1996). Expression
of TCR/CD3 and CD28 in the transfectants and in the 531-B7 cells, phosphorylation of Vav-1 and p120-110
was enhanced, and new phosphoproteins of approxi-CH7C17 parental line is shown in Figure 1A. B2 was a
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Figure 2. TCR-Induced Tyrosine Phosphory-
lation Is Modulated by CD28 Engagement
(A) CD28Neg (B2), WT (A14), and Del.30 (F5)
cells (3  106 ) were incubated for 1.5 min at
37C with medium () or 106 531 cells (531)
(left panel) or with 106 531-B7 cells not pulsed
(B7) or pulsed with SEB (SEB) at the indi-
cated concentrations (right panel). Postnuclear
NP-40 lysates were analyzed by anti-phos-
photyrosine (Ptyr) immunoblotting (IB). () in-
dicates that NP-40 lysates from the unstimu-
lated T cell lines were mixed with lysates of
531 cells (106 ). The lower panel shows re-
probing with mAb against Zap-70 to control
for equal loading. The band above Zap-70 in
lane 5 of the right panel was not specific.
Similar results were obtained with CD28WT
(C20) and two other CD28Del.30 transfec-
tants (H15, E1) (not shown).
(B) Lysates from the same cells stimulated
as in (A) were immunoprecipitated with anti-
p62Dok Ab and analyzed for tyrosine phos-
phorylation.
mately 160, 140, 76, 70, and 36 kDa appeared (Figure mation, which facilitates TCR engagement as measured
by the induction of tyrosine phosphorylation events.2A) whose intensity increased with the dose of SEB.
These latter changes reflected, therefore, TCR ligation.
Interestingly, the intensity of p62Dok phosphorylation in- Selective Defect in TCR-Controlled Tyrosine
Phosphorylation of PLC1 and SLP-76versely correlated with SEB concentration (Figures 2A
and 2B), suggesting that TCR triggering counteracts the in CD28Del.30 Mutants
The defect in IL-2 gene activation in CD28Del.30 cellseffect of CD28, either by reducing the levels of p62Dok
recruitment or by specifically inducing its dephosphory- (Figure 1B) could result from decreased TCR-promoted
early biochemical changes. Indeed, two major effectslation. CD28Neg cells were also extremely inefficient in
promoting TCR-mediated tyrosine phosphorylations of were produced by CD28 tail deletion on inducible tyro-
sine phosphorylations (Figure 2A). First, B7.1 did notp160, p140, p76, p70, and p36 in the presence of SEB.
Identical results were obtained by comparing CH7C17 induce phosphorylation of p120-110, Vav-1, and p62Dok
in CD28Del.30. However, phosphorylation of p120-110(CD28Neg) with C20 (CD28WT) matched for similar TCR/
CD3 surface expression (data not shown). Anti-CD3 Abs and Vav-1, albeit reduced compared to CD28WT cells,
induced similar levels of tyrosine phosphorylation in
CD28Neg and CD28WT cells, indicating that the ab-
sence of CD28 did not cause a TCR signaling defect
(data not shown).
Defective tyrosine phosphorylation in CD28Neg cells
might be due to insufficient bridging with the APC, ren-
dering TCR ligation inefficient. Figure 3 demonstrates
that CD28WT and 531-B7 cells formed conjugates
(30%) already after 2 min at 37C, whereas CD28Neg
cells were unable to do so (2.5%), and no change
was observed at later time points (data not shown). The
addition of CTLA4-Ig or the use of 531 cells lacking B7.1
abolished the formation of conjugates (data not shown), Figure 3. Absence of CD28 Affects Conjugate Formation
confirming the implication of CD28 as a major provider CD28Neg (B2), WT (A14), and Del.30 (F5) cells (3.5  106 ) were
incubated at 37C for 2 min with 531-B7 cells (1.2  106 ) previouslyof cell-cell contact in our system. Conjugate formation
pulsed (SEB) or not (B7) with SEB (0.5 g/ml). Conjugates, analyzedin the presence or absence of CD28 did not increase if
by FACS, are expressed as mean percentage  SD of triplicateSEB was present at a high dose (Figure 3), indicating
(SEB) or duplicate (B7) samples. This experiment is representativethat the TCR/SEB/class II interaction did not increase
of three using the above cells and CD28Neg (CH7C17), WT (B6),
cell-cell contact, likely reflecting low TCR occupancy and Del.30 (H15) transfectants (not shown). The time and cell con-
compared to CD28 (see Discussion). These results centrations at which conjugate formation and tyrosine phosphoryla-
tion were detected were approximately the same.showed that CD28 promotes T cell/APC close approxi-
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Figure 4. Optimal Tyrosine Phosphorylation of PLC1 and SLP-76 but Not Zap-70 and Lat Depends on the Integrity of the CD28 Intracellular
Region
Cell transfectants were stimulated as in Figure 2 with 531-B7 cells pulsed or not with different concentrations of SEB (g/ml). Cell lysates
were immunoprecipitated with (A) anti-Zap-70; (B) anti-Lat; (C) anti-PLC1; and (D) anti-SLP-76 Abs. In (B), the dissimilar appearance of the
Lat protein is due to immunoblotting with two different anti-Lat Abs. In (C), the middle bar shows phosphorylated Lat coprecipitated with
PLC1 more readily detectable at 0.5 g/ml. Clones utilized: (A; B; C, lower panel; and D) B2 (CD28Neg), A14 (CD28WT), and F5 (CD28Del.30).
Time course (min) of PLC1 (C, lower panel) and SLP-76 (D, right panel) tyrosine phosphorylation in A14 and F5 stimulated with SEB-pulsed
531-B7 cells (0.05 g/ml). Immunoprecipitates were analyzed by immunoblot with anti-Ptyr Ab. Stripped membranes were reprobed with the
Abs against the precipitated proteins.
was induced by TCR engagement (SEB). Second, when ylation of PLC1 in CD28Del.30 cells (Figure 4C, lower
panels). Phosphorylated Lat coprecipitating with PLC1compared to CD28WT cells, p160, p140, and p76 were
considerably decreased in intensity at all doses of SEB (Zhang et al., 2000) was similar in both CD28WT and
CD28Del.30 cells, strongly suggesting that, in the lattertested, whereas p70 and p36 appeared unchanged. This
selective phosphorylation defect was not due to a de- case, the levels of PLC1 recruited to Lat were un-
changed but not efficiently phosphorylated. As ex-creased T cell/APC contact, as demonstrated by the
equal percentages of conjugate formed by CD28Del30 pected, minimal PLC1 phosphorylation was detected
in SEB-stimulated CD28Neg cells (Figure 4C). p76 wasand CD28WT cells (Figure 3). From their apparent molec-
ular masses, p140, p76, p70, and p36 could be PLC1, identified as being SLP-76, and, as predictable from the
analysis of total lysates (Figure 2), its phosphorylationSLP-76, Zap-70, and Lat, respectively, all key elements
connecting the TCR to various intracellular signaling on tyrosine was substantially impaired in CD28Del.30
compared to CD28WT cells (Figure 4D). Similarly topathways. Indeed, the presumed identity of these mo-
lecular species proved to be correct (Figure 4). Consis- PLC1, delayed phosphorylation kinetics was excluded
for SLP-76 (Figure 4D). Anti-CD3-induced phosphopro-tent with the lack of conjugate formation, CD28Neg cells
exhibited weak inducible tyrosine phosphorylation of tein profiles were identical in CD28Del.30 and CD28WT
cells (data not shown). Thus, the selective decrease inZap-70 (Figure 4A) and very low or no detectable Lat
phosphorylation after SEB stimulation (Figure 4B). In PLC1 and SLP-76 phosphorylation in CD28Del.30
transfectants was not due to altered intrinsic TCR signal-contrast, tyrosine phosphorylation of Zap-70 and Lat
was comparable in CD28WT and CD28Del.30 cells stim- ing capacity. Comprehensively, our results revealed that
under close-to-physiological stimulatory setting condi-ulated for 1.5 min with different doses of SEB (Figures
4A and 4B), and no appreciable difference was noticed tions (e.g., T cell/APC conjugates and limited TCR occu-
pancy), the lack of signaling from CD28 selectively af-at later time points (30 min) (data not shown), indicating
that initiation and persistence of these TCR-mediated fects TCR-directed tyrosine phosphorylation of PLC1 and
SLP-76 while sparing other more proximal events, suchevents was not compromised by the lack of CD28 signal.
These data were confirmed several times with this pair as the phosphorylation of Zap-70 and its substrate Lat.
of transfectants (e.g., A14 and F5) as well as with others
(C20 versus H15 and E1) matched for CD28 and CD3 Signals from the CD28 Intracellular Tail Critically
Contribute to Amplify Ca2 Flux and NFAT Activationexpression (Figure 1). In contrast, PLC1 tyrosine phos-
phorylation was drastically reduced at all SEB doses in Response to TCR Triggering
TCR/CD3-induced tyrosine phosphorylation of PLC1 hastested in CD28Del.30 compared to CD28WT cells (Figure
4C). Kinetics experiments ruled out a delayed phosphor- been correlated with its enzymatic activation and an in-
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Figure 5. Optimal Ca2 Response and NFAT Activation Depend on the Integrity of the CD28 Intracellular Region
(A) Fluo-3-AM-loaded cells (1.5  106 ) were added to confluent monolayers of 531-B7 cells pulsed with SEB (open symbols) at 1 (a and b)
or 0.5 g/ml (c). In parallel, T cells were incubated with 531 cells to monitor basal levels of [Ca2]i (hatched symbols). Changes in [Ca2]i were
detected at 37C every 24 s for 10 min. CD28WT cells (circles) were A14 (a) and C20 (b and c). CD28Del.30 cells (squares) were F5 (a), E1 (b),
and H15 (c).
(B) Cells were transfected with NFAT luciferase reporter and stimulated after 24 hr with SEB-pulsed 531-B7. The name of each clone utilized
is indicated in parentheses.
crease in [Ca2]i (Park et al., 1991). We therefore tested tion, and recent data have specifically implicated these
PTKs in the phosphorylation of PLC1 (Lewis et al., 2001).whether the decreased tyrosine phosphorylation of PLC1
observed with CD28Del.30 led to a decrease in [Ca2]i. Since CD28 stimulation with Abs triggers tyrosine phos-
phorylation and kinase activation of Itk (August et al.,Ca2 flux was monitored in CD28WT and CD28Del.30
cells after stimulation with SEB-pulsed 531-B7 cells. As 1994), we examined how Itk tyrosine phosphorylation was
controlled when CD28 or CD28 and TCR together wereshown in Figure 5A, all three CD28Del.30 transfectants
exhibited reduced [Ca2]i as compared with CD28WT engaged (Figure 6). Stimulation of CD28WT cells by 531-
B7 led to detectable Itk phosphorylation, which was notcells. In addition, maximal [Ca2]i peaked 1–2 min later
in CD28Del.30 cells. Overall, a 50%–70% reduction was noticeably enhanced even when coengaging the TCR at
a concentration of SEB (0.5 g/ml) inducing high levels ofobserved with the different CD28Del.30 transfectants.
Consistently, NFAT activation was substantially reduced IL-2 gene activation (Figure 1B). In contrast, Itk phosphory-
lation was not observed in CD28Del.30 cells triggered byin CD28Del.30 cells stimulated with SEB-pulsed 531-B7
cells compared with CD28WT, though it was higher than 531-B7 (Figure 6) and was weakly detected upon SEB and
B7 stimulation after longer exposure of the blots (data notthe response of CD28Neg cells (Figure 5B). Altogether,
these results illustrate that one role of CD28 intracellular shown). To further evaluate the role of Itk through CD28,
we overexpressed the kinase in CD28Del.30 cells, whichsignaling is to enhance the PLC1/Ca2/calcineurin
pathway. efficiently form conjugates with 531-B7 cells, but are im-
paired in NFAT activation. When compared with CD28WT
cells transfected with the empty vector (Figure 6B), NFATCD28 Supplies Activated Itk to TCR-Controlled
Signaling Pathways activation was substantially restored in CD28Del.30 cells
overexpressing Itk, indicating also that the [Ca2]i in-The Tec PTK family (Itk/Emt, Tec, Rlk/Txk) plays an im-
portant role in [Ca2]i increase induced by TCR stimula- crease was restored to some extent. Overexpression of
Immunity
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Figure 6. Preferential Tyrosine Phosphorylation of Itk after CD28 Stimulation and Recovery of NFAT Activation by Itk in CD28Del.30 Cells
(A) CD28WT (A14) and Del.30 (F5) cells were stimulated for 1.5 min at 37C with 531 (B7), 531-B7 (B7), or 531-B7 pulsed with SEB at 0.5
g/ml (B7/SEB). Immunoprecipitated Itk was analyzed for tyrosine phosphorylation (upper panel) and, after membrane stripping, with anti-
Itk Ab (lower panel). The slower migrating band above Itk in the upper panel was not observed in other experiments.
(B) CD28Neg B2 (triangles), WT A14 (circles), and Del.30 F5 (squares) cells were transfected with pSR	 vector (20 g), empty (empty symbols)
or encoding Itk (closed symbols) together with NFAT luciferase reporter. Cells were then stimulated with SEB-pulsed 531-B7 or with PMA/
A23187 (the response to PMA/A23187 was similar in cells transfected with empty and Itk-encoding vectors). Inset, comparable Flag epitope
expression in the indicated cells. One representative experiment of three is shown in (A) and (B).
Itk in CD28Neg cells had no effect, likely a consequence activation, Akt phosphorylation, which was more ele-
vated after CD3 and CD28 coligation than with CD3of poor TCR engagement due to impaired T cell/APC
conjugate formation (Figures 2 and 3). These data are alone, was also sensitive to the inhibition of PI3K. A
similar inhibition of PLC1 and Akt phosphorylation wasconsistent with a mechanistic role of the CD28 intracel-
lular tail in providing activated Itk to the TCR signaling observed in CD28WT cells stimulated with SEB-pulsed
B7 cells, although at 2.5 higher concentrations ofmachinery, an event contributing to amplification of the
PLC1/Ca2 pathway (Figure 5A). Ly294002 (data not shown). These results indicate a role
of PI3K in the stabilization and/or activation of PLC1
at the membrane.CD28-Controlled PLC1 Phosphorylation in Normal
Human CD4 T Cells and Its Modulation by PI3K
We investigated whether the selective contribution of Discussion
CD28 to the PLC1/Ca2 pathway applies also to normal
T cells. Purified human CD4 T cells were stimulated at CD28/B7-Mediated T Cell/APC Contact
Enhances TCR Engagementa suboptimal concentration of anti-CD3 Ab (to represent
less than 10% of occupied TCR/cell as detected by Early studies suggested that CD28/B7 interaction pro-
motes the formation of cell-cell interactions (Linsley etFACS analysis) to mimic low TCR occupancy. CD28 or
CD3 ligation induced a barely detectable increase in al., 1990). Later, it was proposed that CD28, together
with CD2, facilitates the formation of the T cell/APCPLC1 tyrosine phosphorylation above background
(Figure 7A). However, coligation of both CD3 and CD28 contact zone (Davis and van der Merwe, 1996). Recently,
it was shown that conjugate formation between primarystrongly enhanced PLC1 phosphorylation. In contrast,
Zap-70 tyrosine phosphorylation induced by anti-CD3 T cells lacking CD28 and a B cell line utilized as APCs
was partially impaired and further reduced if CD2 wasligation was not significantly influenced by CD28 coliga-
tion (Figure 7A). Similar results were obtained in Jurkat also absent (Green et al., 2000). Thus, the diminished
response to antigen might be partly attributed to defec-cells (data not shown). Consistent with an activation
of PLC1, anti-CD28 costimulation strongly augments tive cell-cell contacts (Green et al., 2000), suggesting a
physiological relevance of the adhesive forces exerted[Ca2]i induced by suboptimal concentrations of anti-
CD3 Abs in human normal T cells (Zaru et al., 2001). As by CD28 (and CD2). Moreover, it was demonstrated that
anti-B7.1/B7.2 Abs inhibited Zap-70/ phosphorylationCD28 is known to bind and activate PI3K (Pages et al.,
1994), we examined the possibility that the PI(3, 4, 5)P3 in primary Tg-TCR CD4 T cells stimulated by antigen-
loaded activated APC (Tuosto and Acuto, 1998). Our(PIP3) or PI(3, 4)P2 (PIP2) products of PI3K activity facili-
tate phosphorylation of PLC1 as a consequence of studies fill the gap between these different observations
by showing that, by bringing closer the T cell and APCinteracting with its PH domain (Falasca et al., 1998) or
by an indirect mechanism. Resting CD4 cells, starved membranes, CD28/B7 interaction facilitates the initia-
tion of TCR signaling. CD28/B7-mediated conjugate for-in low-serum conditions treated with Ly294002 and stim-
ulated by CD3 and CD28, exhibited a dose-dependent mation did not require CD28 signal and was unaffected
by Src PTKs or PI3K pharmacological inhibitors suchinhibition of PLC1 phosphorylation, whereas Zap-70
was minimally affected (Figure 7B). As a control for PI3K as PP1, wortmannin, or Ly294002 (unpublished data),
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ment was much in favor of CD28/B7.1 compared to
TCR/SEB/class II. This conclusion is consistent with the
reconstituted Jurkat cells’ expressing levels of CD28
higher than the TCR (5 fold; Figure 1A). More impor-
tantly, similar densities of B7 and class II were expressed
on the APC, whereas the SEB concentrations used
(25–50 nM) should correspond to a low class II occu-
pancy (KD  1–10 M for SEB/DR1) (Li et al., 1999).
Comparable solution affinities have been estimated for
TCR interaction with SEB (and for V
3.1 expressed on
CH7C17 cells) (Li et al., 1999) and for CD28 association
to B7.1 (van der Merwe et al., 1997). Thus, CD28 occu-
pancy must be higher than that of the TCR. This may
reproduce a condition often encountered, for example,
by primary T cells stimulated by an activated dendritic
cell. Our experimental system was designed on purpose
to dissect CD28 molecular functioning only, and, conse-
quently, the initial formation of conjugates depended
exclusively on the CD28/B7 couple. However, a similar
mechanism is likely to apply to CD2/LFA3. Indeed, both
CD2 and CD28 have been shown to be required in pri-
mary T cells to form conjugates with dendritic cells
(Hauss et al., 1995).
Selective Influence of CD28 on Lat-Recruited
Signaling Components
We found that TCR-induced Zap-70 activation with con-Figure 7. Tyrosine Phosphorylation of PLC1 in Resting CD4 Cells Is
sequent Lat phosphorylation and their persistence wasPromoted by CD28 Coligation with CD3 and Is Influenced by PI-3
Kinase independent of a CD28 signal. However, at low TCR
(A) Purified human CD4 T cells (20  106 ) were incubated with occupancy, this signal was mandatory for effective tyro-
medium, anti-CD3 (UCHT1, ascites 1/105 ), anti-CD28 (CD28.2, 5 g/ sine phosphorylation of PLC1 and SLP-76, the former
ml), or both at 4C for 30 min. Cells were washed, warmed at 37C being the most affected. Indeed, full PLC1 activation
for 5 min, then incubated with anti-IgG1 (10g/ml) for 2 min. Lysates
was dependent on a CD28-generated signal, since theof 15  106 and 4  106 cells were immunoprecipitated with anti-
Ca2 response induced by TCR ligation was clearly re-PLC1 or anti-Zap-70 Abs, respectively, and analyzed by immu-
duced with the CD28Del.30 mutant (Figure 5A) or withoutnoblot with anti-Ptyr Ab.
(B) Purified CD4 T cells were starved overnight in medium containing Ab ligation of CD28 in human T cells (Zaru et al., 2001).
0.5% FCS, then incubated for 3 hr at 37C (30  106 /ml) in RPMI The following conclusions can be drawn from these re-
containing DMSO () or Ly294002 (20 and 100 M). Cells were then sults. First, the Zap-70/Lat signaling axis of T cell activa-
stimulated as in (A) except that anti-CD3 was utilized at 0.5 g/ml. An
tion appears to be controlled by the level of TCR engage-aliquot of lysates was analyzed with anti-phospho-Akt. One represen-
ment, which depends on facilitation of cell-cell contacttative experiment of three is shown. Numbers indicate the ratios of
(to which CD28 contributes), antigen abundance, andtyrosine phosphorylation to protein signals as described in Experimen-
tal Procedures. The average inhibition of CD28-induced PLC1 phos- kinetics of TCR ligation. From our data, it seems unlikely
phorylation from the three experiments was 75% at 100 M of that CD28 signaling contributes to the transportation of
Ly294002 and 20% for anti-CD3-induced Zap-70 phosphorylation. activated Src PTKs (e.g., Lck/Fyn) toward the TCR to
facilitate signal initiation and persistence, although we
cannot exclude the possibility that the CD28 transmem-suggesting that the underlying cell-cell contact process
relies exclusively on the avidity of the CD28/B7.1 interac- brane segment and the first 11 residues of the cyto-
plasmic tail may contribute to this function. Second, ation. We conclude that a CD28-mediated “adhesion ef-
fect,” whose magnitude should depend on B7 density below-the-threshold TCR signal could be raised by
CD28 (Viola and Lanzavecchia, 1996), which suppliesand binding affinity (e.g., B7.1 versus B7.2), facilitates
TCR engagement. This may be the initial costimulatory “activated components” to the TCR-controlled signaling
apparatus. We have identified one of them as being Itk.function of CD28. Other studies found no evidence for
a role for CD28 in facilitating TCR engagement, using Upon TCR triggering, PLC1 becomes phosphory-
lated on tyrosine and activated after association withas a criterion TCR downregulation (Bachmann et al.,
1997). This discrepancy may be partly explained by dif- Lat. The N-SH2 domain of PLC1 binds to Lat (Stoica
et al., 1998; Zhang et al., 2000), presumably to the phos-ferent sensitivities in determining TCR engagement
(e.g., downregulation versus tyrosine phosphorylation) pho-YLVV sequence. A recent model proposes that such
an association is stabilized by an interaction betweenand/or by a low dependency on costimulation of the
responses examined, or else by insufficient density of the SLP-76/Gads complex and PLC1 (Yablonski et al.,
2001). We found that the levels of phosphorylated LatB7 on the APC used. We noticed that TCR ligation by
SEB/class II alone or together with CD28 by B7.1 did not bound to PLC1 (Figure 4C) were unchanged in the
absence of CD28 signaling. This suggests that the ineffi-promote or augment conjugate formation, respectively
(Figure 3), suggesting that the stoichiometry of engage- cient phosphorylation/activation of PLC1 was not due
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to a defective recruitment on Lat, but to a decreased much higher density of ligands (e.g., B7.2, B7.1 on an
activated dendritic cell may exceed 105 ) with whichrecruitment or activation of a PTK. Likely candidates are
members of the Tec PTK family, as T cells lacking Itk CD28 interacts with affinities comparable to those of
the TCR for peptide/MHC (van der Merwe et al., 1997).(Liu et al., 1998) or both Itk and Rlk (Schaeffer et al.,
1999) have impaired PLC1 phosphorylation and Ca2 Thus, CD28 (together with CD2) may serve as a “sealing”
device for the T cell and APC plasma membranes againstresponse. The lack of Itk tyrosine phosphorylation in
CD28Del.30 cells, which could only be slightly compen- repulsive forces and facilitate reaching TCR ligands
(Davis and van der Merwe, 1996). In turn, CD28 shouldsated by TCR engagement (Figure 6), is consistent with
the idea that activation of Itk by CD28 critically contrib- favor accumulation and activation of signaling compo-
nents (e.g., Vav-1, Itk/Tec, Akt, and p62Dok) that the TCRutes to PLC1 phosphorylation and activation. This idea
is strengthened by the substantial recovery of NFAT acti- is unable to generate in sufficient amounts due to limiting
peptide/MHC concentration. Here, we have providedvation in CD28Del.30 cells overexpressing Itk. In Jurkat
cells, the PI3K-generated PIP3 regulates Itk/Tec mem- the example of Itk. Assembly of a Lat/SLP-76 scaffold-
ing, whose concentration is set by the levels of TCRbrane localization after TCR ligation (Ching et al., 1999;
Yang et al., 2001), though these cells have elevated basal engagement (e.g., binding half-life and numbers of li-
gated TCRs), provides the “reaction center” wherePIP3 levels due to the lack of 3 lipid phosphatase PTEN
expression (Shan et al., 2000). Our data show that a CD28- CD28-activated Itk (and/or Tec) kinase enhances activa-
tion of Lat-recruited PLC1. By its specialized functionmediated increase of PLC1 phosphorylation in normal
T cells depends in part on PIP3 production. This is in line of recruiting PI3K and the consequent augmentation
of PIP3, CD28 may stabilize the spatial alignment andwith recent studies of mice that express CD28 mutated
at the PI3K binding site, demonstrating a partial alter- functional activation of PLC1 and Tec/Itk by favoring
the interaction of their PH domains with the plasmaation of early signaling and impaired in vivo T cell func-
tions (Burr et al., 2001; Harada et al., 2001). The PI3K membrane. The selective enhancement of PLC1 activa-
tion via CD28 has interesting implications, since increas-dependency suggests a stabilizing role of PIP3/PH for
PLC1 and/or Itk/Tec for membrane localization and ing the diacylglycerol level contributes also to the activa-
tion of the Ras pathway (Dower et al., 2000). Finally, ittheir activation (Ching et al., 1999; Falasca et al., 1998).
CD28 signaling also contributes to tyrosine phosphor- remains to be understood why the p62Dok adaptor, which
downmodulates BCR signaling (Yamanashi et al., 2000),ylation of Vav-1 (Michel et al., 1998; Nune`s et al., 1994)
and SLP-76 (this study). Vav-1, whose exchange activity is paradoxically recruited and phosphorylated upon
CD28 ligation. Our finding that TCR ligation selectivelyis upregulated by tyrosine phosphorylation, is required
in T cells for optimal [Ca2]i increase and ERK activation, antagonizes p62Dok tyrosine phosphorylation suggests
a preventive mechanism that maintains a positive signalbut not for PLC1 phosphorylation (Costello et al., 1999).
We recently showed that CD28 engagement lowers the by costimulatory receptors.
TCR triggering threshold by a mechanism dependent on
the SH2 domain of Vav-1 and on TCR-recruited SLP-76
Experimental Procedures(Michel et al., 2000). However, in contrast to Itk, Vav-1
overexpression in CD28Del.30 cells did not restore Cells
NFAT activation after SEB/B7 stimulation (unpublished CH7C17, a Jurkat T cell line expressing a (V	1.2/V
3.1) TCR was
maintained as previously described (Hewitt et al., 1992). CH7C17data). These data suggest that Vav-1 and Itk may differ-
cell transfectants were grown in the same medium supplementedently regulate NFAT and AP-1 transcription factors and
with 4 mg/ml G418. 5-3.1 L cells expressing HLA-DRB1*0101 (531)that two controls are operated by CD28: one via a Tec
and B7-1 (531-B7) were cultured in complete DMEM medium with 50PTK-activating phosphorylation of PLC1 and the other
g/ml of hygromycin B. Human CD4 T cells were isolated (90%–96%
through Vav-1 activation. How CD28 contributes to purity) by negative selection using a CD4 kit and the Automacs
phosphorylation of SLP-76 is unclear. However, Itk can apparatus (Miltenyi Biotec, Paris, France). Cells were rested in com-
plete RPMI medium supplemented with sodium pyruvate and nones-bind to SLP-76 and Rlk/Txk phosphorylates SLP-76
sential amino acids.(Bunnell et al., 2000; Schneider et al., 2000). Moreover,
missing interactions of SLP-76 with its partners (e.g.,
Itk and Vav-1) might lead to decreased phosphorylation
Antibodies and Other Reagents
of SLP-76 as a consequence of augmented exposure Mouse mAbs were anti-phosphotyrosine 4G10, anti-PLC1, anti-Itk
to tyrosine phosphatases. 2F12 (UBI, Lake Placid, NY), anti-Zap-70 (clone 29, Transduction
Lab, Lexington, KY), anti-CD28.2 (Coulter, Marseille, France), UCHT1
anti-CD3 (Cymbus Biotechnologies, Chandlers Ford, UK), and anti-Quantitative and Qualitative Contributions of CD28:
Flag (Sigma France, St Quentin Fallavier, France). Polyclonal AbsSelective Supply of Signaling Components to
were anti-Zap-70, anti-Lat, and anti-p62Dok, kindly provided by Drs.
Compensate for the Paucity of TCR Engagement J.M. Rojo (Madrid, Spain), L. Samelson (NIH, Bethesda, MD), and
Under natural conditions of antigen presentation, the D. Olive (Marseille, France), respectively; anti-Itk (UBI); anti-PLC1;
TCR signal may often be weak and/or of short duration anti-phospho-Akt (Ser473); and anti-Akt (C-20) (Santa Cruz Biotech-
nology, Santa Cruz, CA). Rabbit anti-human SLP-76 and Lat di-and therefore insufficient to achieve the activation
rected, respectively, against residues 1–12 and 219–233 were gener-threshold. This threshold may be lowered by CD28 en-
ated in our laboratory. Sheep polyclonal anti-SLP-76 was fromgagement acting at different levels. An antigen-loaded
Upstate Biotechnology. Goat anti-IgG1 was from Southern Biotech-APC normally presents limiting concentrations of poten-
nology Associates (Birmingham, AL). SEB was purchased from
tial TCR ligands (a few hundred), which interact weakly Toxin Technology (Sarasota, FL). Ly294002 was from Calbiochem
with the TCR (e.g., with low affinities and high off-rates) (San Diego, CA). PMA (12.5 ng/ml) and the calcium ionophore
A23187 (0.5 g/ml) were from Sigma.(Li et al., 1999). In contrast, the same APC displays a
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cDNA (a gift of Dr. W. Ellmeier, Wien, Austria) was subcloned in Recherche sur le Cancer, and the Centre National pour la Recherche
PSR	-puro vector. pH
APr-1-neo encoding CD28 wild-type or trun- Scientifique.
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